Abstract
Background
Despite the best clinical practice, chronic nonhealing ulcers of the lower extremities present a significant challenge. Nitric oxide (NO) has been shown to play a significant role in biological functions including wound healing and as an antimicrobial agent in nonspecific immune response.
Objective
Our goal was to study the effect of gaseous NO (gNO) administered directly to a two-year-old nonhealing chronic venous ulcer in a 55-year-old male presenting with a 30-year history of severe venous disease.
Methods
gNO (200 ppm) was applied to the lower extremity using a delivery system connected to a “single patient use” plastic boot, at 1.0 L/min.
Results
The patient received an average of 8.1-h treatments for 14 consecutive nights. On day 0 the wound was malodorous and covered by bacterial biofilm with little healthy granulation tissue present. Following 3 days of gNO treatment, healthy granulation tissue was noted with absence of malodorous odor. At day 14, the ulcer was significantly reduced in size (p = 0.014) and almost completely reepithelialized. Day 10 post-treatment did not reveal any deterioration in healing. Six weeks later, the wound was 90% healed. At 26 weeks post gNO discontinuation, the ulcer was completely healed.
Conclusions
This single case study demonstrated that gNO as a topical agent was well tolerated by the patient without any report of discomfort or side effect. The result of wound healing was very promising and warrants future exploration.
Sommaire
Antécédents
Malgré les meilleures pratiques cliniques, les ulcères chroniques non guérissables des membres inférieurs représèntent un défi de taille. Il a été démontré que le monoxyde d’azote (NO) joue un rôle important dans les fonctions biologiques, notamment la cicatrisation des plaies, et agit comme agent antimicrobien dans les réponses immunitaires aspécifiques.
Objectif
Administrer du NO gazeux directement sur un ulcère veineux chronique non guérissable de deux ans, chez un patient âgé de 55 ans souffrant de maladies veineuses graves depuis 30 ans.
Methodes
200 ppm de NO gazeux ont été appliqués sur les membres inférieurs au moyen d’un système de livraison connecté à des bottes en plastique à usage unique, à 1lpm
Résultats
Le traitement de 14 nuits consécutives a nécessité en moyenne 8,1 heures. Au jour 0, la plaie était malodorante et couverte de mucilage bactérien, avec peu de tissu de granulation sain. Après trois jours de traitement au NO gazeux, on a noté la présence de tissu de granulation sain avec une absence de mauvaise odeur. Au jour 14, la taille de 1’ulcère a été réduite considérablement (p = 0,014) et une réépithélialisation presque complète a eu lieu. Au jour 10 après la fin du traitement, aucun signe de détérioration n’a été détecté. Six semaines plus tard, la plaie était guérie à 90 %. À la 26e semaine suivant la fin du traitement, l’ulcére était complétement guéri.
Conclusion
Ce cas unique montre que le NO gazeux comme médicament topique a été bien toléré par le patient sans mention de sensations gênantes ni d’effets secondaires. Les résultats de la guérison sont très prometteurs et méritent une exploration plus poussée.
Similar content being viewed by others
References
D. Krasner (1990) Chronic wound care: a clinical source book for healthcare professionals Health Management Publications City 12–18
KL McCance SE Heuther (1998) Pathophysiology: The biologic basis for disease in adults, children EditionNumber3 C.V. Mosby St. Louis 232–234
B Kunimoto M Cooling W Gulliver et al. (2001) ArticleTitleBest practices for the prevention and treatment of venous leg ulcers Ostomy Wound Manage 47 IssueID2 34–46, 48–50
C Hannson J Hoborn A Moller et al. (1995) ArticleTitleThe microbial flora in venous leg ulcers without clinical signs of infection Acta Derm Venerol 75 24–30 Occurrence Handle7747531
JW Costerton PS Stewart EP. Greenberg (1999) ArticleTitleBacterial biofilms: a common cause of persistent infections Science 284 1318–1322 Occurrence Handle10.1126/science.284.5418.1318 Occurrence Handle10334980
JW Costerton PS. Stewart (2001) ArticleTitleBattling biofilms Sci Am 285 75–81
PS Stewart JW. Costerton (2001) ArticleTitleAntibiotic resistance of bacteria in biofilms Lancet 358 135–138 Occurrence Handle10.1016/S0140-6736(01)05321-1 Occurrence Handle11463434
S Moncada RMJ Palmer EA. Higgis (1991) ArticleTitleNitric oxide. Physiology, pathophysiology and pharmacology, Pharmacol Rev 43 109–134 Occurrence Handle1852778
MA Groote ParticleDe FC. Fang (1995) ArticleTitleNO inhibitions: antimicrobial properties of nitric oxide Clin Infect Dis 21 IssueIDSuppl 2 S162–165 Occurrence Handle8845445
MB Witte A. Barbul (2002) ArticleTitleRole of nitric oxide in wound repair Am J Surg 183 406–412 Occurrence Handle10.1016/S0002-9610(02)00815-2 Occurrence Handle11975928
FC. Fang (1997) ArticleTitleMechanisms of nitric oxide-related antimicrobial activity Am Soc Clin Invest 99 IssueID12 2818–2825
A VazQuez–Torres FC. Fang (1999) Therapeutic applications of nitric oxide in infection Nitric Oxide and Infection Plenum New York 475–488
AD Ormerod P Copeland I Hay et al. (1999) ArticleTitleThe inflammatory and cytotoxic effects of a nitric oxide releasing cream on normal skin J Invest Dermatol 113 392–397 Occurrence Handle10.1046/j.1523-1747.1999.00692.x Occurrence Handle10469339
JA Bauer R Weisan DJ. Smith (1998) ArticleTitleEvaluation of linear polyethyleneimine/NO adduct on wound repair: therapy versus toxicity Wound Repair Regen 6 569–577 Occurrence Handle10.1046/j.1524-475X.1998.60609.x Occurrence Handle9893176
M Shabini SK Pulfer JP Bulgrin et al. (1996) ArticleTitleEnhancement of wound repair with a topically applied nitric oxide-releasing polymer Wound Repair Regen 4 353–362 Occurrence Handle10.1046/j.1524-475X.1996.40312.x
M Kavdia S Nagarajan RS. Lewis (1998) ArticleTitleNovel devices for the predictable delivery of nitric oxide to aqueous solutions Chem Res Toxicol 11 1346–1351 Occurrence Handle10.1021/tx980112s Occurrence Handle9815196
R Weller AD Ormerod RP Hobson et al. (1998) ArticleTitleA randomized trial of acidified nitrite cream in the treatment of Tinea pedis J Am Acad Dermatol 38 559–563 Occurrence Handle9555794
JBJ Hardwick AT Tucker M Wilks et al. (2001) ArticleTitleA novel method for the delivery of nitric oxide therapy to the skin of human subjects using a semi-permeable membrane Chem Sci (Lond) 100 395–400
A Ghaffari A Ardakani DH Neil et al. (2002) In vitro antibacterial effect of gaseous nitric oxide on common bacterial strains contributing to wound infections: Pseudomonas aeruginosa and Staphylococcus aureus 2nd International Conference of Nitric Oxide Prague Czech Republic
Ghahary A, Ghaffari A, Miller C. In vivo effects of exogenous gaseous nitric oxide on Staphylococcus aureus infection in a healing rabbit wound model (abstract). In: Wound Caring Symposium, Canadian Association of Wound Care, Vancouver, Canada, November 2002, pp 23–24.
A Ghaffari C Miller A Ardakani et al. (2003) ArticleTitleExogenous nitric oxide gas in chronic wound infection Wound Repair Regen 11 IssueID2 A11 Occurrence Handle10.1046/j.1524-475X.2003.11104.x
Ghaffari A, Ardakani A, Miller CC, et al. Viability of human fibroblast cells exposed to gaseous nitric oxide. In: 8th Annual Conference of the Canadian Association of Wound Healing, Vancouver, Canada, 2002.
B Stallmeyer H Kampfer N Kolb et al. (1999) ArticleTitleThe function of NO in wound repair: inhibition of iNOS severely impairs wound reepithelialization J Invest Dermatol 113 1090–1098 Occurrence Handle10.1046/j.1523-1747.1999.00784.x Occurrence Handle10594757
HP Shi D Most DT Efron et al. (2003) ArticleTitleSupplemental L-arginine enhances wound healing in diabetic rats Wound Repair Regen 11 198–203 Occurrence Handle10.1046/j.1524-475X.2003.11308.x Occurrence Handle12753601
A Barbul RS Fishel S Shimazu et al. (1985) ArticleTitleIntravenous hyperalimentation with high arginine levels improves wound healing and immune function J Surg Res 38 328–334 Occurrence Handle10.1016/0022-4804(85)90045-9 Occurrence Handle3923266
K Yamasaki HDJ Edington C McClosky et al. (1998) ArticleTitleReversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer J Clin Invest 101 967–971 Occurrence Handle9486966
R Wang A Ghahary YJ Shen et al. (1996) ArticleTitleHuman dermal fibroblasts produce nitric oxide and express both constitutive and inducible NOS isoforms J Invest Dermatol 106 419–427 Occurrence Handle10.1111/1523-1747.ep12343428 Occurrence Handle8648170
V Krischel D Bruch–Gerharz Suschek et al. (1998) ArticleTitleBiphasic effect of exogenous NO on proliferation and differentiation in skin-derived keratinocytes but not fibroblasts J Invest Dermatol 111 286–291 Occurrence Handle10.1046/j.1523-1747.1998.00268.x Occurrence Handle9699731
E Noiri T Peresleni N Srivastava et al. (1996) ArticleTitleNO is necessary for a switch from stationary to locomoting phenotype in epithelial cells Am J Physiol 270 c794–802 Occurrence Handle8638659
PC Lee AN Salyapongse GA Bragdon et al. (1999) ArticleTitleImpaired wound healing and angiogenesis in eNOS-deficient mice Am J Physiol 277 IssueID4 pt 2 H1600–H1608 Occurrence Handle10516200
S Frank B Stallmeyer H Kampfer et al. (1999) ArticleTitleNitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair FASEB J 13 2002–2014 Occurrence Handle10544183
Acknowledgments
We would like to thank the team at Pulmonox for their support of this study, in particular Mr. Robert Lee and Bruce Murray for their expert technical assistance in construction of the device. We would also like to thank Alex Stenzler of Viasys Healthcare for his invaluable input and encouragement.
Chris Miller currently is employed as CEO of PulmoNOx Medical Inc. Minna Miller is related to Chris Miller.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Miller, C.C., Miller, M.K., Ghaffari, A. et al. Treatment of Chronic Nonhealing Leg Ulceration with Gaseous Nitric Oxide: A Case Study. J Cutan Med Surg 8, 233–238 (2004). https://doi.org/10.1007/s10227-004-0106-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10227-004-0106-8